|
|
|
|
| LEADER |
01366cam a2200313 a 4500 |
| 001 |
16883492 |
| 003 |
Ost |
| 005 |
20180406184807.0 |
| 008 |
110721s2011 enk b 001 0 eng c |
| 999 |
|
|
|c 10995
|d 10995
|
| 015 |
|
|
|a GBB070815
|2 bnb
|
| 016 |
7 |
|
|a 015572813
|2 Uk
|
| 020 |
|
|
|a 9781841139531 (hbk.)
|
| 020 |
|
|
|a 184113953X (hbk.)
|
| 082 |
|
|
|a 346.048
|b YAM'11
|
| 100 |
1 |
|
|a Yamane, Hiroko.
|
| 245 |
1 |
0 |
|a Interpreting TRIPS :
|b globalisation of intellectual property rights and access to medicines /
|c Hiroko Yamane.
|
| 246 |
3 |
|
|a Interpreting Agreement on Trade-Related Intellectual Property Rights
|
| 246 |
3 |
0 |
|a Globalisation of intellectual property rights and access to medicines
|
| 260 |
|
|
|a Oxford ;
|b Hart Publishing,
|c 2011.
|
| 300 |
|
|
|a xlvi, 535 p.
|c
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 630 |
0 |
0 |
|a Agreement on Trade-Related Aspects of Intellectual Property Rights
|d (1994 April 15)
|
| 650 |
|
0 |
|a Intellectual property (International law)
|
| 650 |
|
0 |
|a Intellectual property (International law)
|x Economic aspects.
|
| 650 |
|
0 |
|a Pharmaceutical industry.
|
| 856 |
4 |
1 |
|3 Table of contents only
|u http://www.loc.gov/catdir/toc/fy11pdf03/2011290433.html
|
| 942 |
|
|
|2 ddc
|c REF
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 346_048000000000000_YAM11
|7 0
|8 REF
|9 21407
|a NUALS
|b NUALS
|c REF
|d 2018-04-06
|l 0
|o 346.048 YAM'11
|p 14824
|r 2018-04-06
|w 2018-04-06
|y REF
|